TD Cowen on Bio-Techne Corp. (TECH): 'Sell-Off Looks Overdone, We'd Be Buyers on Today's Weakness'

March 17, 2026 8:47 AM

TD Cowen analyst Kyle Boucher reiterated a Buy rating and $80.00 price target on Bio-Techne Corp. (NASDAQ: TECH).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found